Polymeropoulos Mihael Hristos
SEC CIK 1355537 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| VNDA | Vanda Pharmaceuticals Inc. | Pres, CEO, Dir, COB | 2.70M | $504.8K | $4.78M | 24 | 2021-11-30 | 2026-03-02 |
Most active insiders at VNDA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Polymeropoulos Mihael Hristos | Pres, CEO, Dir, COB | — | $1.28M |
| 2 | Moran Kevin Patrick | SVP, CFO, Treas | — | $351.0K |
| 3 | Williams Timothy | SVP, GC | — | $350.9K |
| 4 | Birznieks Gunther | SVP, Business Development | — | $350.9K |
| 5 | Wijkstrom Joakim | SVP, CMO | — | $254.7K |
| 6 | Honore Tage | Dir | — | $240.9K |
| 7 | McGuire Daniel Patrick | SVP, GC, Sec | — | — |
| 8 | Duncan Charles Cliff | Dir | — | — |
| 9 | Mitchell Stephen Ray | Dir | — | — |
| 10 | Ward Anne Sempowski | Dir | — | — |
Transactions 24
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-04 | 2026-03-02 | VNDA | Vanda Pharmaceuticals Inc. | Polymeropoulos Mihael Hristos | Pres, CEO, Dir, COB | S - Sale | $8.17 | -156.2K | 2.70M | -5% | -$1.28M | |
| 2026-02-19 | 2026-02-18 | VNDA | Vanda Pharmaceuticals Inc. | Polymeropoulos Mihael Hristos | Pres, CEO, Dir, COB | A - Grant | $0.00 | +525.0K | 2.86M | +22% | $0 | |
| 2025-08-08 | 2025-08-07 | VNDA | Vanda Pharmaceuticals Inc. | Polymeropoulos Mihael Hristos | Pres, CEO, Dir, COB | P - Purchase | $4.15 | +10.0K | 2.34M | +0.4% | +$41.5K | |
| M | 2025-05-21 | 2025-05-21 | VNDA | Vanda Pharmaceuticals Inc. | Polymeropoulos Mihael Hristos | Pres, CEO, Dir, COB | P - Purchase | $4.40 | +10.0K | 2.33M | +0.4% | +$44.0K |
| 2025-05-19 | 2025-05-16 | VNDA | Vanda Pharmaceuticals Inc. | Polymeropoulos Mihael Hristos | Pres, CEO, Dir, COB | P - Purchase | $4.22 | +20.0K | 2.32M | +0.9% | +$84.4K | |
| M | 2025-03-06 | 2025-03-06 | VNDA | Vanda Pharmaceuticals Inc. | Polymeropoulos Mihael Hristos | Pres, CEO, Dir, COB | P - Purchase | $5.01 | +10.0K | 2.29M | +0.4% | +$50.1K |
| M | 2025-03-05 | 2025-03-05 | VNDA | Vanda Pharmaceuticals Inc. | Polymeropoulos Mihael Hristos | Pres, CEO, Dir, COB | P - Purchase | $5.02 | +10.0K | 2.29M | +0.4% | +$50.2K |
| 2025-03-04 | 2025-03-01 | VNDA | Vanda Pharmaceuticals Inc. | Polymeropoulos Mihael Hristos | Pres, CEO, Dir, COB | F - Tax | $4.76 | -96.0K | 2.27M | -4% | -$457.0K | |
| 2025-03-04 | 2025-03-03 | VNDA | Vanda Pharmaceuticals Inc. | Polymeropoulos Mihael Hristos | Pres, CEO, Dir, COB | P - Purchase | $4.71 | +10.0K | 2.28M | +0.4% | +$47.1K | |
| 2025-02-28 | 2025-02-28 | VNDA | Vanda Pharmaceuticals Inc. | Polymeropoulos Mihael Hristos | Pres, CEO, Dir, COB | P - Purchase | $4.76 | +10.0K | 2.36M | +0.4% | +$47.6K | |
| 2025-02-27 | 2025-02-27 | VNDA | Vanda Pharmaceuticals Inc. | Polymeropoulos Mihael Hristos | Pres, CEO, Dir, COB | P - Purchase | $4.76 | +10.0K | 2.35M | +0.4% | +$47.6K | |
| M | 2025-02-26 | 2025-02-26 | VNDA | Vanda Pharmaceuticals Inc. | Polymeropoulos Mihael Hristos | Pres, CEO, Dir, COB | P - Purchase | $4.76 | +10.0K | 2.34M | +0.4% | +$47.6K |
| 2025-02-25 | 2025-02-25 | VNDA | Vanda Pharmaceuticals Inc. | Polymeropoulos Mihael Hristos | Pres, CEO, Dir, COB | P - Purchase | $4.46 | +10.0K | 2.33M | +0.4% | +$44.6K | |
| 2025-02-20 | 2025-02-18 | VNDA | Vanda Pharmaceuticals Inc. | Polymeropoulos Mihael Hristos | Pres, CEO, Dir, COB | A - Grant | $0.00 | +450.0K | 2.32M | +24% | $0 | |
| M | 2024-03-06 | 2024-03-04+ | VNDA | Vanda Pharmaceuticals Inc. | Polymeropoulos Mihael Hristos | Pres, CEO, Dir, COB | S - Sale | $4.19 | -55.2K | 1.87M | -3% | -$231.3K |
| 2024-02-21 | 2024-02-16 | VNDA | Vanda Pharmaceuticals Inc. | Polymeropoulos Mihael Hristos | Pres, CEO, Dir, COB | A - Grant | $0.00 | +450.0K | 1.93M | +30% | $0 | |
| M | 2023-03-06 | 2023-03-02+ | VNDA | Vanda Pharmaceuticals Inc. | Polymeropoulos Mihael Hristos | Pres, CEO, Dir, COB | S - Sale | $6.24 | -45.0K | 1.48M | -3% | -$280.6K |
| D | 2023-02-21 | 2023-02-16 | VNDA | Vanda Pharmaceuticals Inc. | Polymeropoulos Mihael Hristos | Pres, CEO, Dir, COB | A - Grant | $0.00 | +115.0K | 1.52M | +8% | $0 |
| DM | 2022-12-07 | 2022-12-05+ | VNDA | Vanda Pharmaceuticals Inc. | Polymeropoulos Mihael Hristos | Pres, CEO, Dir, COB | M - OptEx | $3.12 | +150.0K | 1.46M | +11% | +$468.0K |
| DM | 2022-12-07 | 2022-12-05+ | VNDA | Vanda Pharmaceuticals Inc. | Polymeropoulos Mihael Hristos | Pres, CEO, Dir, COB | S - Sale+OE | $10.61 | -95.9K | 1.41M | -6% | -$1.02M |
| D | 2022-03-02 | 2022-02-28 | VNDA | Vanda Pharmaceuticals Inc. | Polymeropoulos Mihael Hristos | Pres, CEO, Dir, COB | A - Grant | $0.00 | +115.0K | 1.39M | +9% | $0 |
| DM | 2022-03-02 | 2022-03-01+ | VNDA | Vanda Pharmaceuticals Inc. | Polymeropoulos Mihael Hristos | Pres, CEO, Dir, COB | S - Sale | $11.16 | -37.1K | 1.35M | -3% | -$413.9K |
| DM | 2021-12-02 | 2021-11-30+ | VNDA | Vanda Pharmaceuticals Inc. | Polymeropoulos Mihael Hristos | Pres, CEO, Dir | M - OptEx | $4.88 | +150.0K | 1.32M | +13% | +$732.0K |
| DM | 2021-12-02 | 2021-11-30+ | VNDA | Vanda Pharmaceuticals Inc. | Polymeropoulos Mihael Hristos | Pres, CEO, Dir | S - Sale+OE | $16.25 | -96.2K | 1.25M | -7% | -$1.56M |
Purchase Sale Sale after option exercise All abbreviations